Rare diseases
Investigational molecules
Locations
Back to France2 221 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides
FranceStudy of ISIS 678354 for Patients with Severe Hypertriglyceridemia
FranceStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
FranceStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
FranceStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
FranceStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
FranceStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
FrancePhase 3 Study of Zigakibart (BION-1301) in Adults with IgA Nephropathy
FranceEfficacy and Safety Evaluation of Tulisokibart in Moderate to Severe Hidradenitis Suppurativa: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Trial
FranceEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
FranceStudy on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
